Description
A mixture of ganglioside GM2 isolated from bovine brain with primarily C18:0 fatty acyl chain lengths; induces activated T cell death at 150 μg/ml in vitro; serum levels are increased in patients with breast cancer or cholangiocarcinoma; levels are elevated in the brain of patients with Sandhoff disease; accumulates in the lysosomes of individuals with Tay-Sachs disease and GM2-activator deficiency, as well as in the CNS of patients with and animal models of mucopolysaccharide storage disorders and Niemann-Pick disease types A, C1, and C2
Formal name:
Synonyms: GM2 Mixture|Monosialoganglioside GM2 Mixture
Molecular weight: 1,401.70
CAS: 19600-01-2
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cancer|Immunology||Research Area|Cell Biology|Endomembrane System & Vesicular Trafficking||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience|Neurodegenerative Disorders